Marie H Hanigan

Title: Marie H. Hanigan: Innovator in Gamma-Glutamyl Transpeptidase Inhibitors

Introduction

Marie H. Hanigan is a notable inventor based in Edmond, OK (US). She has made significant contributions to the field of biochemistry, particularly in the development of gamma-glutamyl transpeptidase inhibitors. With a total of 2 patents, her work focuses on innovative methods for treating various diseases.

Latest Patents

Hanigan's latest patents include compositions that effectively inhibit gamma-glutamyl transpeptidase (GGT). These compositions are designed for use in both in vivo and in vitro settings. The methods outlined in her patents aim to inhibit and kill neoplastic cancer cells, providing potential treatments for tumors and malignant growths in mammals. Additionally, her GGT inhibitor compounds, which comprise a class of benzylthiadiazol benzenesulfoniamides, may also be utilized to treat reversible airways obstruction and related diseases such as asthma and chronic obstructive pulmonary disease (COPD). Other conditions that may benefit from her research include degenerative diseases, renal diseases, liver diseases, cardiovascular diseases, and inner ear conditions.

Career Highlights

Marie H. Hanigan is affiliated with the University of Oklahoma, where she continues her research and development efforts. Her work has garnered attention for its potential impact on cancer treatment and respiratory diseases.

Collaborations

One of her notable collaborators is Pui Kai Li, who has worked alongside Hanigan in her research endeavors.

Conclusion

Marie H. Hanigan's innovative work in gamma-glutamyl transpeptidase inhibitors showcases her commitment to advancing medical science. Her contributions have the potential to significantly improve treatment options for various diseases.